Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

SmithKline Beecham reports novel hemoregulatory compounds

July 8, 1997

Phase I results reported for Cortecs' oral insulin

July 7, 1997

Proteoglycan synthesis increased by rhBMP-2

July 7, 1997

SmithKline Beecham and Nycomed disclose hemoregulatory compounds

July 7, 1997

Pharmacia & Upjohn discloses agents for diabetes

July 7, 1997

Low serum cholesterol levels increase risk of suicide in certain psychiatric disorders

July 4, 1997

Icos PDE V inhibitor in phase I trials

July 4, 1997

Exocell presents new small-molecule antiglycation agent

July 4, 1997

Rebamipide for diabetic nephropathy

July 3, 1997

Edex cleared for erectile dysfunction in the U.S.

July 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...